//
Zhenya Senyak
Ruben A. Mesa
Nicolaus Kroeger
Koen Van Besien
Wael Saber
Richard T. Silver
Attilio Orazi
Jeanne Palmer
Claire N. Harrison
Srdan Verstovsek
Uday Popat
Michelle J Woerhle
Ann Brazeau
Barbara Van Husen
Martin Prager
Chris Harper
Beatrice Larroque
Robyn Marie Scherber
MPNforum, Asheville, NC
UT Health San Antonio Cancer Center, San Antonio, TX
Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,
Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY
The Medical College of Wisconsin, Milwaukee, WI
Richard T. Silver Myeloproliferative Neoplasms Center, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY
Weill Cornell Medical College, New York, NY
Division of Hematology & Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
Department of Virology, Royal Free Hospital, London, United Kingdom
Department of Radiology, MD Anderson Cancer Center, Houston, TX
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
MPN Research Foundation, Chicago, IL
MPN Advocacy and Education, Chicago, IL
MPNforum, Asheville, NC
MD Anderson Mays Cancer Center, University of Texas Health San Antonio, San Antonio, TX
United States
Germany
United Kingdom
N/A
Oncology (ONC)
Myeloid neoplasms
MPL proto-oncogene, thrombopoietin receptor
Calreticulin
Enhancer of zeste homolog 2
Isocitrate dehydrogenase 1
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon
EZH2
N/A
N/A
NA
N/A
N/A
N/A